Literature DB >> 11756945

Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?

Cem Evereklioglu1, Yusuf Turkoz, Hamdi Er, H Serhat Inaloz, Emin Ozbek, Mustafa Cekmen.   

Abstract

BACKGROUND: The origin of Behçet's disease (BD) is unclear. One of the prominent features of BD is vasculitis and thrombosis as a result of endothelial dysfunction. Because nitric oxide (NO) is synthesized by endothelium, we considered it as an interesting target of investigation in BD.
OBJECTIVE: Our purpose was to define the level of NO in the serum of patients with BD and its relation with disease activity.
METHODS: As an indicator for NO, serum total nitrite levels (end product of NO) were measured by Griess reaction in 52 consecutive patients with BD and compared with 32 age- and sex-matched healthy staff volunteers. Serum NO levels of active and inactive patients were compared.
RESULTS: The overall serum nitrite levels in patients with BD (40.25 +/- 10.51 micromol/L) were significantly higher (P <.001) than those in healthy volunteers (25.09 +/- 5.33 micromol/L). The difference in serum total nitrite levels among patients with active BD (46.74 +/- 10.62 micromol/L) and inactive BD (33.24 +/- 3.73 micromol/L) was significant (P <.001). Significant differences were observed in serum nitrite levels between patients in the inactive period of BD and the control group (P <.001).
CONCLUSION: Increased NO production might be responsible for the overall inflammatory process of BD. NO seems to be related to disease activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756945     DOI: 10.1067/mjd.2002.118338

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  26 in total

1.  DNA damage and its relationship with other oxidative stress parameters in Behcet's disease.

Authors:  E D Sezer; K Aksu; O Caglayan; G Keser; G Karabulut; G Ercan
Journal:  Rheumatol Int       Date:  2010-09-14       Impact factor: 2.631

2.  5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.

Authors:  Y Ozkul; C Evereklioglu; M Borlu; S Taheri; M Calis; M Dündar; O Ilhan
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Diagnostic dilemma between intestinal Behçet disease and inflammatory bowel disease with pyoderma gangrenosum.

Authors:  Cem Evereklioglu
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

4.  Leptin levels in Henoch-Schönlein purpura.

Authors:  Yuksel Aliyazicioglu; Ozan Ozkaya; Husamettin Yakut; Ismail Islek; Muhlise Alvur
Journal:  Clin Rheumatol       Date:  2006-07-01       Impact factor: 2.980

5.  Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.

Authors:  Murat Yuksel; Abdulkadir Yildiz; Mustafa Oylumlu; Fatih Mehmet Turkcu; Mehmet Zihni Bilik; Aysun Ekinci; Bilal Elbey; Ebru Tekbas; Sait Alan
Journal:  Clin Rheumatol       Date:  2015-03-07       Impact factor: 2.980

6.  Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.

Authors:  Cem Evereklioglu; Hamdi Er; Selim Doganay; Mustafa Cekmen; Yusuf Turkoz; Baris Otlu; Elif Ozerol
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

7.  Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease.

Authors:  H Er; C Evereklioglu; T Cumurcu; Y Türköz; E Ozerol; K Sahin; S Doganay
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

8.  Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.

Authors:  Mustafa Calis; Filiz Ates; Cevat Yazici; Kader Kose; Mehmet Kirnap; Meltem Demir; Murat Borlu; Cem Evereklioglu
Journal:  Rheumatol Int       Date:  2005-05-03       Impact factor: 2.631

9.  Neurotological status in Behçet's disease and its ophthalmological correlates.

Authors:  Y A Bayazit; C Evereklioğlu; E Ozer; N Kirtak; N Bayazit; M Kanlikama; S Inalöz
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

10.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.